KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

ClearPoint Neuro (CLPT) Short-term Investments (2022 - 2023)

ClearPoint Neuro's Short-term Investments history spans 2 years, with the latest figure at $9.9 million for Q1 2023.

On a quarterly basis, Short-term Investments changed N/A to $9.9 million in Q1 2023 year-over-year; TTM through Mar 2023 was $9.9 million, a N/A change, with the full-year FY2022 number at $9.9 million, changed N/A from a year prior.
Short-term Investments hit $9.9 million in Q1 2023 for ClearPoint Neuro, roughly flat from $9.9 million in the prior quarter.
Over the last five years, Short-term Investments for CLPT hit a ceiling of $21.7 million in Q3 2022 and a floor of $9.9 million in Q4 2022.